查詢結果分析
相關文獻
- Role of Thymectomy in the Treatment of Myasthenia Gravis
- Pre-and Perioperative Management of Thymectomy for Myasthenia Gravis
- The use of Atracurium in Chinese Myasthenic Patients Undergoing Thymectomy
- 重肌無力症之受體抗體檢查
- 大餐之後,四肢無力甲狀腺毒性週期性肌無力症簡介
- 以免疫吸附血漿析離療法治療重症肌無力症之評估
- 重症肌無力症危象的加護照顧
- Thymomatous Myasthenia Gravis
- 重症肌無力症之血漿分離術療法
- Coexistence of Epilepsy, Myasthenia Gravis and Psoriasis Vulgaris
頁籤選單縮合
題 名 | Role of Thymectomy in the Treatment of Myasthenia Gravis=胸腺切除術治療肌無力症 |
---|---|
作 者 | 黃敏雄; 金光亮; 乾光宇; | 書刊名 | 中華民國外科醫學會雜誌 |
卷 期 | 20:2 1987.03[民76.03] |
頁 次 | 頁123-131 |
分類號 | 416.226 |
關鍵詞 | 胸腺切除術; 肌無力症; |
語 文 | 英文(English) |
中文摘要 | 從民國68年10月至民國73年12月,在台北榮民總醫院總共有77例非胸腺瘤之肌無力症接受胸腺切除手術。其中74例在手術後有仔細追踪。在此74例中,男性病患18例,女性病患56例。年齡從13歲至68歲,平均30.2歲。疾病持續的時間由一個月至三十年,平均為4.2年。 胸腺切除是經由正中胸骨切聞,包括胸腺以及前縱隔與兩側肋膜心包膜間之脂肪組織全部切除至兩側之橫隔神經為主。胸腺切除後之結果令人滿意。74例當中之70例(94.6%)的病人明顯得到益處,在這些病患當中,34例(46%)症狀完全消失,不須藥物之治療,36例(48.6%)有實質上的進步。只有3例(4%)在胸腺切除後症狀並無改進,然而,在手術後,其症狀也沒有更進一步的惡化或是更需要大量藥物來維持。 胸腺切除術治療肌無力症,在肌無力症之治療上已經成為標準的方法。在輕度或是中等度全身性肌無力症的痛息,愈早施行胸腺切除術,將會得到十分令人滿意的結果。 |
英文摘要 | From October 1979 to December 1984, 77 cases of non-thymomatous myasthenia gravis underwent thymectomy at the Veterans General Hospital, Taipei, Republic of China. Seventy-four patients have had careful followup stlldy and review. Patients with thymoma associated with myasthenia gravis were excluded from this study. Among these 74 patients, 18 were male and S6 female. The ages ranged from 13 to 68 years with an average of 30.2 years. Fifty-two of these 74 patients (70.3%) were young adults whose ages ranged from 21 to 40 years. Men tend to be affected at a later age (The average age for men was 38,0 years and of women, 26.1 years). The duration of disease was from 1 month to 30 years, with an average of 4.2 years. Stemal-splitting extended thymectomy was done to remove all anterior mediastinal fat between the bilateral pleuropericardial reflection and the phrenic nerve. Preliminary results followin thymectomywere very satisfactory. Seventy of the 74 follow-up patients (94.6%) benefited from thymectomy. Of these, 34 patients (46%) had remission and 36 patients (48.6%) had substantial improvement; 3 patients (4%) showed no improvement but did not advance to more severe symptoms nor require more medication. Thymectomy remains a standard method in the treatment of myasthenia gravis. This paper describes experience in the management of the problem. Early thymectomy is recommended for mildly or moderately generalized cases of myasthenia, since surgery in such patients may prevent further deterioration and also promote early total remission. |
本系統中英文摘要資訊取自各篇刊載內容。